Discovery of Tarantula Venom-Derived NaV1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis
Authors:
- Bin WuBWBin Wu
- Justin K. MurrayJMJustin K. Murray
- Kristin L. AndrewsKAKristin L. Andrews
- Kelvin ShamKSKelvin Sham
- Jason LongJLJason Long
- Jennifer AralJAJennifer Aral
- Joseph LiguttiJLJoseph Ligutti
- Shanti AmagasuSAShanti Amagasu
- Dong LiuDLDong Liu
- Anruo ZouAZAnruo Zou
- 22 October 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 61 (21) , 9500-9512
Abstract
Inhibitors of the voltage-gated sodium channel NaV1.7 are being investigated as pain therapeutics due to compelling human genetics. We previously identified NaV1.7-inhibitory peptides GpTx-1 and JzTx-V from tarantula venom screens. Potency and selectivity were modulated through attribute-based positional scans of native residues via chemical synthesis. Herein, we report JzTx-V lead optimization to identify a pharmacodynamically active peptide variant. Molecular docking of peptide ensembles from NMR into a homology model-derived NaV1.7 structure supported prioritization of key residues clustered on a hydrophobic face of the disulfide-rich folded peptide for derivatization. Replacing Trp24 with 5-Br-Trp24 identified lead peptides with activity in electrophysiology assays in engineered and neuronal cells. 5-Br-Trp24 containing peptide AM-6120 was characterized in X-ray crystallography and pharmacokinetic studies and blocked histamine-induced pruritis in mice after subcutaneous administration, demonstrating systemic NaV1.7-dependent pharmacodynamics. Our data suggests a need for high target coverage based on plasma exposure for impacting in vivo end points with selectivity-optimized peptidic NaV1.7 inhibitors.Keywords
This publication has 39 references indexed in Scilit:
- The Role of Science in Addressing the Opioid CrisisNew England Journal of Medicine, 2017
- NaV1.7 as a pain target – From gene to pharmacologyPharmacology & Therapeutics, 2017
- The structure, dynamics and selectivity profile of a NaV1.7 potency-optimised huwentoxin-IV variantPLOS ONE, 2017
- Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3aScientific Reports, 2017
- Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitorScientific Reports, 2017
- The pain drainNature, 2016
- Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical IndicationsJournal of Medicinal Chemistry, 2015
- Recent progress in sodium channel modulators for painBioorganic & Medicinal Chemistry Letters, 2014
- The NaV1.7 sodium channel: from molecule to manNature Reviews Neuroscience, 2012
- ProTx-II, a Selective Inhibitor of NaV1.7 Sodium Channels, Blocks Action Potential Propagation in NociceptorsMolecular Pharmacology, 2008